Japanese Encephalitis Vaccine
Awarded Award Notice Posted
- Solicitation number
- SPE2DP-18-R-0111
- Agency
- Clothing and Textiles Troop Support, Department of Defense
- Awarded
- to Valneva Usa, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2DP-19-D-0001 Federal IDV award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support has awarded a one-year firm-fixed price indefinite quantity contract to supply between 420,000 to 500,000 doses of purified, inactivated Japanese Encephalitis Vaccine per year. The vaccine must be Vero Cell culture derived, contain no stabilizers or preservatives, be latex free, licensed by the FDA, suitable for intramuscular administration, and intended for active immunization against Japanese Encephalitis for persons 2 months and older. Doses shall be delivered to the Defense Distribution Depot Susquehanna within 120 days of order placement under the contract.
Notice text
3 versions
Update #3 · Latest ·
Awarded Vendors: Valneva USA, Inc.. Contract Award Dollar Amount: $70,051,600. Contract Award Date: 2019-01-15.
Update #2 ·
The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Vaccine (JEV), NSN 6505-01-607-7018. The vaccine shall be purified, inactivated, Vero Cell culture derived, contain no stabilizers, Thimerosal/Preservative free, Latex free, licensed by the Food and Drug Administration (FDA), suitable for intramuscular administration and intended for active immunization against Japanese Encephalitis disease. The vaccine shall be a sterile 0.5 ml suspension in a pre-filled syringe (Type 1 glass) with a plunger stopper (chlorobutyl elastomer) with or without a separate needle. The vaccine must be approved by the United States FDA for administration to persons 2 months and up.
The proposed contract will be a one (1) year firm-fixed price indefinite quantity contract.
The estimated annual minimum requirement is 420,000 doses and the estimated maximum is 500,000 doses.
Ordered quantities shall be delivered to the Defense Distribution Depot Susquehanna. Delivery is to be FOB Destination and delivered within 120 days from date of the delivery order.
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell JEV before award of the contract.
Solicitation SPE2DP-18-R-0111 is expected to be issued approximately June 2018 and can be found on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. The point of contact is Danielle Delaney, DLA Troop Support-FSA, 215-737-2998.
The Solicitation will be issued under authority 10 U.S.C. 2034 (c) 1, only one responsible source.
.
Update #1 ·
Added: May 24, 2018 3:47 pm
The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Vaccine (JEV), NSN 6505-01-607-7018. The vaccine shall be purified, inactivated, Vero Cell culture derived, contain no stabilizers, Thimerosal/Preservative free, Latex free, licensed by the Food and Drug Administration (FDA), suitable for intramuscular administration and intended for active immunization against Japanese Encephalitis disease. The vaccine shall be a sterile 0.5 ml suspension in a pre-filled syringe (Type 1 glass) with a plunger stopper (chlorobutyl elastomer) with or without a separate needle. The vaccine must be approved by the United States FDA for administration to persons 2 months and up.
The proposed contract will be a one (1) year firm-fixed price indefinite quantity contract.
The estimated annual minimum requirement is 420,000 doses and the estimated maximum is 500,000 doses.
Ordered quantities shall be delivered to the Defense Distribution Depot Susquehanna. Delivery is to be FOB Destination and delivered within 120 days from date of the delivery order.
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell JEV before award of the contract.
Solicitation SPE2DP-18-R-0111 is expected to be issued approximately June 2018 and can be found on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. The point of contact is Danielle Delaney, DLA Troop Support-FSA, 215-737-2998.
The Solicitation will be issued under authority 10 U.S.C. 2034 (c) 1, only one responsible source.
Attachments
| File | Type | Posted |
|---|---|---|
| J&A_for_posting_Redacted.pdf | ||
| JEV_Signed_Award.pdf | ||
| Final_JEV_Solicitation.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity